Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Truist Financial Co.

Galmed Pharmaceuticals Ltd.
Start price
€6.40
18.11.25 / 50%
Target price
€90.58
18.11.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time.
Performance without dividends (%)
Name 1w
Galmed Pharmaceuticals Ltd. -
iShares Core DAX® 1.659%
iShares Nasdaq 100 0.381%
iShares Nikkei 225® 2.102%
iShares S&P 500 0.221%

Comments by Truist_Financial_Co_ for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 90.584
Change
Ends at 18.11.26

Globus Medical (NYSE:GMED) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $105.00 price target on the stock, up previously from $93.00.
Ratings data for GMED provided by MarketBeat

Truist Financial Co. 
0
Report Share
18.11.25

Stopped prediction by Truist_Financial_Co_ for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
07.11.25
€80.60
07.11.26
-
19.09.24

Truist Financial Co. 
07.11.25 50%